Drugmakers Play The Patent Game To Lock In Prices, Block Competitors
(By Sarah Jane Tribble for Kaiser Health News) David Herzberg was alarmed when he heard that Richard Sackler, former chairman
Read More
Part D/Prescription Drugs
Making a plan to deal with costly healthcare
Far too many senior fail to address one of the most important expenses they are likely to incur: healthcare expenses.
Read MoreGilead to launch generic version of its controversially priced hepatitis C drugs
(By Alia Paavola for Becker’s Hospital Review ) Gilead Sciences will offer a cheaper version of its blockbuster hepatitis C
Read MoreCongress releases final opioids bill: 4 things to know
(By Harrison Cook for Becker’s Hospital Review ) Congress revealed a 660-page revised opioids bill the night of Sept. 25
Read MoreInsulin prices could be much lower and drug makers would still make healthy profits
(By Ed Silverman for ST A T) A s prices for diabetes treatments continue to roil consumers, a new study
Read MoreMisconceptions about switching Medicare Advantage plans
Medicare beneficiaries can change their Medicare Advantage or Medicare Prescription drug (Part D) coverage during the Medicare Annual Election Period
Read MoreDon’t make these two common mistakes during Medicare open enrollment
Medicare’s open enrollment period is nearing – it runs from October 15 through December 7 – giving you a golden
Read MoreCongress won’t include PhRMA-backed Medicare change in opioids package
(By Nicholas Florko and Lev Facher for ST A T) WASHINGTON — The latest version of a bill to address
Read MoreShould drug prices be included in direct-to-consumer ads?
In June 2017, the American Medical Association issued a statement supporting consumer groups, patient advocates and other medical professional societies
Read MorePicking the right Medicare Plans during open enrollment
Each year you have from October 15 to December 7 to pick a Medicare Part D prescription drug plan, or
Read More